Pharmaceuticals News

ALBANY, Nueva York, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), una organización líder mundial en desarrollo y fabricación por contrato (CDMO), anunció hoy una inversión...

ออลบานี รัฐนิวยอร์ก, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia) องค์กรชั้นนำระดับโลกด้านการวิจัย พัฒนา และรับจ้างผลิต (Contract, Development and Manufacturing Organization: CDMO)...

Pistol and Paris Launches Vanquish Medical Providing Access and Serving Medical Cannabis Patients Across Canada

-24-Month Crossover Analysis: Patients Starting Deramiocel After a Year on Placebo Slowed Upper Limb Decline by 76% Compared with Their Own Prior Year- -At 24 Months, Both Groups Showed Slower...

LOS ANGELES, CA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a global leader in AL Amyloidosis, today announced that it will present at...

Bagsværd, Denmark, 5 October 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of...

DOYLESTOWN, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery...

WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines...

BOSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing targeted therapies for neurodegenerative diseases, today announced the appointment of Karl...

Initial Phase 1b data highlight promising clinical activity in patients with PROC and support continued clinical development of CUSP06 At the September 23, 2026, data cutoff, CUSP06 achieved a 62%...